Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
about
Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.Aspirin and multiple sclerosisRhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell borderRelapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.Contraception for women with multiple sclerosis: Guidance for healthcare providers.Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?The Framingham cardiovascular risk score in multiple sclerosis.Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state.Sedentary Behavior and Blood Pressure in Patients with Multiple Sclerosis.Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
P2860
Q33705173-203C3522-15A4-4A25-83B6-D02B0AE8BBB3Q35678040-10FF4282-46EC-447D-A22C-AB7EC2308689Q36887349-B8E86E7B-C6C4-4530-B6B7-6E9D0069AE09Q37661249-878CB179-7D6F-44BD-926B-28F1DDC62D96Q38689611-C1D3C73B-D67E-463F-9B8B-E50885F53627Q39013846-45E4C027-6344-42C1-8BBA-A05421A15AD1Q39198295-F500D9C5-FFA8-4526-AD77-85A1036599BEQ40555407-D8112DA8-3534-49C0-B6B8-0D645940C28CQ42364978-185454A1-C208-4CF7-9871-BCF43F8914B3Q48195952-17CCC7A2-9F2B-452F-89B9-4E777A872BA7Q48275617-49AC97AF-9990-4249-9632-EE9F74E228E1Q53441006-D04C8402-F81D-4FA7-A492-C037F585E10BQ59137067-E8016A9F-949D-42DF-B7CE-6E872C9FBC7D
P2860
Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@en
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@nl
type
label
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@en
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@nl
prefLabel
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@en
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@nl
P2093
P2860
P356
P1476
Multiple sclerosis clinical co ...... e risk - Swedish cohort study.
@en
P2093
H Roshanisefat
P2860
P304
P356
10.1111/ENE.12518
P577
2014-07-17T00:00:00Z